SAMHSA's FR-CARA Forecast Cuts $34.7M to $20M and 118 Awards to 40 — And Nonprofits Can't Apply At All
November 4, 2026 · 7 min read
Granted Research Team · Editorial policy
Rural, tribal, and faith-based community organizations tracking SAMHSA opioid dollars got their FY2027 signal on October 30, when the agency posted a $20 million forecast for the First Responders–Comprehensive Addiction and Recovery Act program — TI-27-006 — to Grants.gov opportunity 364173.
Two things about that record deserve attention before anyone builds a calendar around it. It is a forecast, not a posted Notice of Funding Opportunity — the application window does not exist yet. And FR-CARA's eligibility is closed by statute in a way that shuts out most community nonprofits as prime applicants. Both facts change what a small organization should do with this news, and neither is obvious from the headline dollar figure.
What the October 30 forecast actually says
The Grants.gov record carries opportunity number TI-27-006, the title "First Responders-Comprehensive Addiction and Recovery Act," and a status of FORECASTED. SAMHSA's Division of Treatment Programs created it on October 30, 2026 at 9:20 a.m. Eastern. The estimated synopsis posting date — the day the real NOFO is expected to appear — is December 15, 2026. The estimated award date is September 30, 2027, the final day of the federal fiscal year.
The forecast's hard numbers:
- $20,000,000 estimated total program funding
- 40 anticipated awards
- Cooperative agreement, not a standard grant
- Assistance Listing 93.490 — Center for Substance Abuse Treatment Projects of Regional and National Significance
- Cost sharing: required
- Program contact: Shannon Hastings, 202-961-8620, DTP-NOFO@samhsa.hhs.gov
The stated purpose runs a single sentence: "to train first responders and communities in administering and distributing opioid overdose reversal medications (OORM)." Twenty million dollars across forty awards implies roughly $500,000 per award, though the forecast publishes no award ceiling or floor.
What the forecast does not contain is an application due date. The field is blank. Anyone telling you FR-CARA has a December deadline is reading the synopsis-posting estimate as a deadline — those are opposite ends of the process.
The three-year arc runs up and then sharply down
FR-CARA has been funded since 2017, and the last three competitions tell a story that the FY2027 forecast interrupts:
| Round | Posted | Due | Window | Total funding | Ceiling | Awards | Cost share |
|---|---|---|---|---|---|---|---|
| TI-24-006 | Feb 14, 2024 | Apr 15, 2024 | 61 days | $6.2M | $800,000 | 15 | No |
| TI-25-001 | Jun 27, 2025 | Jul 22, 2025 | 25 days | $10.0M | $800,000 | 33 | No |
| TI-26-006 | Jul 1, 2026 | Jul 27, 2026 | 26 days | $34.7M | $800,000 | 118 | No |
| TI-27-006 | Oct 30, 2026 (forecast) | not yet set | — | $20.0M est. | not published | 40 est. | Yes |
The FY2026 round was the program's high-water mark by a wide margin: $34.7 million across 118 awards, up from $10 million and 33 awards the year before. FY2027's forecast cuts total funding 42 percent and the award count 66 percent.
But the per-award math moves the other way. TI-26-006 averaged roughly $294,000 per award. TI-27-006's forecast implies about $500,000. Read together, those two numbers describe a deliberate consolidation: SAMHSA appears to be trading breadth for depth, funding fewer sites at larger amounts rather than spreading naloxone-distribution money across a hundred-plus jurisdictions. For a well-resourced county health department, that is good news. For the long tail of small rural and tribal applicants that benefited from a 118-award cycle, the odds just got materially worse.
Eligibility is statutorily closed, and that reframes the whole play
Here is the detail that matters most to community-based organizations, and the one most likely to be reported wrong. The forecast states:
"Eligibility for this program is statutorily limited (Section 546 of the Public Health Service Act [42 USC 290ee-1], as amended) to states, local governmental entities, and Indian Tribes and Tribal organizations (as defined in section 4 of the Indian Self-Determination and Education Assistance Act)."
That language has been consistent across TI-24-006, TI-25-001, and TI-26-006. Note what is absent: domestic public and private nonprofit entities. FR-CARA is not a program where a community nonprofit or a faith-based recovery ministry competes directly. Unlike the broader eligibility universe in SAMHSA's FY26 release — where the SBIRT NOFO explicitly opened to nonprofits, FQHCs, and faith-based providers, as we covered in SAMHSA Just Dropped Eight Grant Programs Totaling $40M Under The Great American Recovery Initiative — FR-CARA's door is statutory and SAMHSA cannot widen it administratively. A nonprofit that submits as prime applicant will be screened out before review.
This splits the ICP segment cleanly in two:
Tribes and tribal organizations are directly eligible. This is the strongest single fact in the forecast for Indian Country. A tribal health department, a tribal EMS program, or a tribal organization as defined under ISDEAA Section 4 can apply as prime. Given that the program's statutory purpose is training and equipping first responders with overdose reversal medication, tribal applicants with their own police, fire, or EMS capacity — or with an existing IHS relationship — are squarely in the intended applicant pool.
Rural and faith-based nonprofits are subrecipients, not applicants. The realistic path is a partnership position inside a county, city, or tribal application: the community organization delivers the training, the community engagement, the distribution network, and the warm hand-off referrals, while the governmental entity holds the award. That is not a consolation prize. TI-24-006's program description required recipients to "establish processes, protocols, and mechanisms for warm hand-off referrals to appropriate treatment, recovery, harm reduction, and other psychosocial resource support services" — which is precisely the work governmental grantees typically subcontract, because county agencies rarely have recovery-community reach of their own.
The cost-share line is the single thing to verify in December
Every FR-CARA round in the three-year table above carried no cost-sharing requirement. The FY2027 forecast flips that field to required.
If it holds in the posted NOFO, it is the most consequential change in the cycle — more consequential than the funding cut. A match obligation is a regressive filter: it costs a state health department almost nothing to satisfy and can be disqualifying for a small tribal organization or a rural county with no discretionary health budget. Matching requirements are exactly the mechanism that converts a nominally open competition into one dominated by applicants with existing institutional funds.
Two caveats, stated plainly. Forecast records are drafted months before the NOFO and their fields are sometimes corrected. And forecast data is non-binding — SAMHSA can revise funding, award count, and cost sharing before December 15, and the agency says so. Treat the cost-share line as a flag to check on day one of the posted NOFO, not as settled fact.
Where rural nonprofits should actually point an application
If your organization is a rural nonprofit that cannot apply to FR-CARA, there is a better-matched forecast sitting on Grants.gov right now: HRSA-27-040, Rural Communities Opioid Response Program – Overdose Response. Its numbers:
- $10.5 million total, 35 awards, $300,000 award ceiling
- No cost-sharing requirement
- Eligibility: "domestic public or private, non-profit or for-profit entity"
- Services restricted to HRSA-designated rural counties and rural census tracts
- Estimated synopsis posting January 11, 2027; estimated applications due March 10, 2027
That is the same problem — rural overdose response — with eligibility that includes you, a ceiling scaled to a community organization, and no match. The sequencing is also favorable: the FR-CARA NOFO is expected roughly four weeks before RCORP's, so an organization can take a partnership role in a county or tribal FR-CARA application in December and still lead its own RCORP-Overdose Response application in the new year.
SAMHSA has a third forecast in the same family worth knowing about, though it is narrower still: TI-27-005, Emergency Department Alternatives to Opioids, limited by 42 U.S.C. 294i-1 to hospitals, freestanding emergency departments, and rural emergency hospitals — with statutory priority for applicants outside the fourteen states where current grantees sit.
Why a 26-day window makes the next six weeks the real work
The strategic case for acting before December has nothing to do with the forecast and everything to do with FR-CARA's recent posting behavior. The FY2025 round gave applicants 25 days. The FY2026 round gave 26 days. The program's 61-day window in FY2024 has not recurred.
Four weeks is not enough time to originate a partnership from scratch — to identify the right county or tribal applicant, negotiate a subrecipient role, secure a letter of commitment, and assemble the overdose data and training protocols that make a naloxone-distribution proposal credible. It is barely enough time to document a partnership that already exists. If TI-27-006 posts on or near December 15 and holds to form, the submission deadline lands in mid-January 2027.
So the work between now and December 15 is relationship work and documentation work, not writing work: confirm which eligible entity in your service area intends to apply, get your role in writing, and have your training reach, distribution points, and referral pathways quantified before the NOFO drops.
Next step: search active opioid and overdose-response opportunities on Granted to see which of these forecasts match your entity type and rural designation before the December window opens.